Results 181 to 190 of about 12,538,458 (271)

Role of independent versus chain pharmacies in providing pharmacy access: a nationwide, individual-level geographic information systems analysis. [PDF]

Health Aff Sch, 2023
Hernandez I, Tang S, Morales J, Gabriel N, Patel N, Mathis WS, Guo J, Berenbrok LA.   +7 more
europepmc   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Too dim, too bright, and just right: Systems analysis of the Chlamydomonas diurnal program under limiting and excess light. [PDF]

Plant Cell
Dupuis S, Ojeda V, Gallaher SD, Purvine SO, Glaesener AG, Ponce R, Nicora CD, Bloodsworth K, Lipton MS, Niyogi KK, Iwai M, Merchant SS.   +11 more
europepmc   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

The Australian wildfires from a systems dependency perspective

Environmental Research Letters, 2020
John Handmer, Stefan Hochrainer-Stigler, Thomas Schinko, Franziska Gaupp, Reinhard Mechler   +4 more
doaj   +1 more source

Primary oral healthcare in Ireland: a health systems analysis of publicly funded contracted services delivered by the general dental practitioner workforce. [PDF]

BMC Health Serv Res
Leavy P, Fleming P, Daly B, Barry S, Burke S.   +4 more
europepmc   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Stressors contributing to burnout among acute care and trauma surgery care teams: a systems-analysis approach. [PDF]

Trauma Surg Acute Care Open
Kwong E, Adapa K, Goodacre V, Vizer L, Ra J, Greenberg C, Ivester T, Charguia N, Marks LB, Mazur L.   +9 more
europepmc   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

A resuscitation systems analysis for South Africa: A narrative review. [PDF]

Resusc Plus
van Rensburg L, Majiet N, Geldenhuys A, King LL, Stassen W.   +4 more
europepmc   +1 more source